RTOG has issued a Request for Proposal for to solicits application to conduct translational research using material obtained from the RTOG clinical trial 0617: A Randomized Phase III Comparison of Standard- Dose (60 Gy) Versus Highdose (74 Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel ± Cetuximab (IND #103444) in Patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer. Applications are due May 21st. For more information please consult the RFP for RTOG 0617 under the Researchers tab on the RTOG Web site.